Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release / 2026-04-17

Posted on April 17, 2026August 3, 2026 By K-STOCK Editor No Comments on [Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release / 2026-04-17

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Daeduck Electronics announced that it plans to release its financial results for Q1 2026 (January 1, 2026 ~ March 31, 2026) on April 29, 2026.

📊 Key Disclosure Contents & Major Figures

1. Advance Notice Overview

  • Company Name: Daeduck Electronics Co., Ltd.
  • Target Fiscal Period: January 01, 2026 ~ March 31, 2026 (Q1 2026)
  • Scheduled Release Date: April 29, 2026

2. Other Reference Details & Material Release Plan

  • Accounting Standards: Consolidated financial statements under K-IFRS
  • Nature of Earnings Data: Provisional figures subject to change during the external auditor’s accounting review
  • Presentation Material Location: Official Daeduck Electronics Website (https://www.daeduck.com) under ‘IR – Performance Data’ after fair disclosure
  • Schedule Modifications: The scheduled release date may change depending on company circumstances.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Earnings Release and Material Publication on Scheduled Date

This disclosure serves as an advance notification regarding the scheduled release date for Q1 2026 financial results and presentation materials. Checking whether the provisional operating results are disclosed and presentation materials are uploaded to the website according to the announced schedule is important to confirm the proper execution of the disclosure process. Relevant details can be verified in subsequent provisional earnings disclosures, the official company website, and future official filings such as periodic reports.

📢 Disclaimer & Source Notice

Fact Source: Financial Supervisory Service DART

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Daeduck Electronics (353200) – Invitation to Investor Relations (IR) / 2026-04-17
Next Post: [Disclosure] Hanwha Systems (272210) – Signs Supply Contract Worth KRW 92.0B with Korea Aerospace Industries for KF-21 Initial Production (EOTGP)

Related Posts

[Disclosure] Hanwha Aerospace (012450) Amends Paid-in Capital Increase Filing to “Applicable” for FTC Reporting Due to Affiliate Participation Disclosures
[Disclosure] Jusung Engineering (036930) – Results of Extraordinary General Meeting of Shareholders / 2024-10-08 Semiconductors
[Disclosure] Samsung Biologics (207940) – Result of Action Such as Prosecution Referral for Violation of Accounting Standards / 2025-07-17 Disclosures
[Disclosure] Jeju Semiconductor (080220) – Setting of Record Date or Closure of Register of Shareholders / 2025-12-11 Semiconductors
[Disclosure] Hanmi Semiconductor (042700) – Decision on Conclusion of Trust Contract for Treasury Stock Acquisition / 2024-09-24 Semiconductors
[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-06-19 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme